文献速递运动医学关节外科

背阔肌与大圆肌前移治疗不可修复肩胛下肌撕裂的返工与临床结局

Return-to-Work and Clinical Outcomes After Anterior Latissimus Dorsi and Teres Major Tendon Transfer for Irreparable Subscapularis Tears.
PubMed 文献 · Am J Sports Med · 2026-04-22

该回顾性病例系列纳入189例不可修复肩胛下肌撕裂患者,评估前路背阔肌与大圆肌(LDTM)肌腱转移后的临床结局与返工情况。结果显示91.0%患者返工(58.2%完全返工,32.8%部分返工),平均返工时间5.4±1.5个月,临床评分与活动度、力量均显著改善,肌腱完整性和职业劳动强度是返工的最强预测因素。

要点

  • 前路LDTM转移治疗不可修复肩胛下肌撕裂后91.0%患者返工,平均5.4±1.5个月。
  • 临床结局显著改善,包括VAS、ASES、Constant评分和SAN评分。
  • 肌腱完整性和职业劳动强度是成功返工的最强预测因素。

核心结论

  • 前路LDTM转移是治疗不可修复肩胛下肌撕裂的可靠有效方法,临床结局良好且返工率高。

研究设计与样本

  • 回顾性病例系列,证据等级4级,纳入189例不可修复肩胛下肌撕裂患者(126男,63女;平均年龄64.4±6.7岁;随访43.4±17.1个月)。

主要发现

  • 91.0%患者返工(58.2%完全返工,32.8%部分返工),较轻工作强度组返工更早且返工率更高。
  • VAS从4.9±1.1降至1.9±1.2,ASES从49.4±10.0升至72.9±14.0,Constant评分从49.1±6.0升至65.8±9.9,SAN评分从48.7±9.4升至73.8±13.9。
  • 活动度和力量也显著改善,不同工作强度组间临床结局无显著差异。
  • 肌腱完整性和职业劳动强度是成功返工的最强预测因素。

关键数值与推荐

  • 纳入标准为不可修复肩胛下肌撕裂伴肌腱内侧回缩和3级或4级脂肪浸润,无晚期盂肱关节炎。
  • 排除标准包括既往骨手术、随访不完整或失访。

临床怎么用

  • 对于不可修复肩胛下肌撕裂且无晚期盂肱关节炎的患者,可考虑前路LDTM转移以改善临床结局和返工。
  • 职业劳动强度较轻和术后肌腱完整的患者返工可能性更高,可用于术前咨询和康复规划。

局限性

  • 回顾性病例系列,证据等级4级,可能存在选择偏倚和混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Irreparable subscapularis tears represent a significant clinical challenge, especially in active patients aiming to preserve shoulder function. Anterior latissimus dorsi and teres major (LDTM) tendon transfer has been proposed to restore internal rotation and anterior shoulder stability; however, data on return-to-work (RTW) outcomes remain limited. PURPOSE/HYPOTHESIS: The study aimed to evaluate clinical outcomes and RTW rates after anterior LDTM transfer in patients with irreparable subscapularis tears, with the hypothesis that the procedure would provide favorable clinical results and a high RTW rate. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: A retrospective review was conducted on patients who underwent LDTM transfer for irreparable subscapularis tears, with or without concomitant supraspinatus involvement. Inclusion criteria were irreparable subscapularis tears with medial tendon retraction and grade 3 or 4 fatty infiltration, without advanced glenohumeral arthritis. Exclusion criteria included prior bone surgery, incomplete follow-up, or loss to follow-up. Clinical assessment included patient-reported outcome measures, such as visual analog scale, American Shoulder and Elbow Surgeons form, Constant score, and Single Assessment Numeric Evaluation, as well as range of motion and strength. Tendon integrity was evaluated via magnetic resonance imaging, and RTW was assessed using structured questionnaires. Multivariable logistic regression was performed to identify factors influencing RTW. RESULTS: Of 215 patients, 189 were included after exclusions (126 male, 63 female; mean ± SD age, 64.4 ± 6.7 years; follow-up, 43.4 ± 17.1 months). Overall, 91.0% returned to work (58.2% complete, 32.8% partial), with lighter work groups achieving earlier and higher return rates. Clinical outcomes improved significantly across the cohort, including visual analog scale (4.9 ± 1.1 to 1.9 ± 1.2), American Shoulder and Elbow Surgeons form (49.4 ± 10.0 to 72.9 ± 14.0), Constant score (49.1 ± 6.0 to 65.8 ± 9.9), and Single Assessment Numeric Evaluation (48.7 ± 9.4 to 73.8 ± 13.9), as well as range of motion and strength. No significant differences were observed among work intensity groups. Tendon integrity and occupational work intensity were the strongest predictors of successful RTW. CONCLUSION: Anterior LDTM transfer is a reliable and effective treatment for patients with irreparable subscapularis tears, resulting in favorable clinical outcomes and high RTW rates. Overall, 91.0% of patients returned to work (58.2% complete, 32.8% partial) at a mean 5.4 ± 1.5 months across all work levels. Lighter occupational demands and intact tendon integrity were strong predictors of successful RTW.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Baek CH, Kim BT, Kim JG, et al. Return-to-Work and Clinical Outcomes After Anterior Latissimus Dorsi and Teres Major Tendon Transfer for Irreparable Subscapularis Tears. Am J Sports Med. 2026. PMID: 42015681. doi:10.1177/03635465261439045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。